PMID- 19572409 OWN - NLM STAT- MEDLINE DCOM- 20091215 LR - 20211020 IS - 1542-0760 (Electronic) IS - 1542-0752 (Print) IS - 1542-0752 (Linking) VI - 85 IP - 10 DP - 2009 Oct TI - Developmental exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin alters postnatal T cell phenotypes and T cell function and exacerbates autoimmune lupus in 24-week-old SNF1 mice. PG - 828-36 LID - 10.1002/bdra.20603 [doi] AB - BACKGROUND: Untreated, more than 95% of female SWR x NZB: F(1) (SNF(1)) mice spontaneously develop a fatal lupus-like glomerulonephritis by 8 months-of-age, while disease onset in males is much slower. METHODS: : Timed-pregnant SNF(1) mice (10 per treatment) were exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on gestational day (GD) 12 by oral maternal gavage with 0, 40, or 80 microg/kg TCDD. RESULTS: Offspring of the TCDD-exposed dams showed numerous alterations in T lineage cells at 24 weeks-of-age. Females but not males showed decreased CD4(+)8(+) and increased CD4(-)8(-) thymocytes. Females also showed increased autoreactive CD4(+)Vbeta17(a+) axillary and inguinal lymph node T cells. Concanavalin A-stimulated splenocytes from prenatal TCDD-treated mice produced decreased interleukin 17 (IL-17) in the females while males showed increased IL-2 and IFN-gamma, and diminished IL-4. Mitogen-stimulated pan-lymphoproliferative responses were significantly increased across sex by TCDD. Anti-IgG and anti-C3 immune complex deposition in kidneys was present in the males after TCDD, and visibly worsened in females. CONCLUSIONS: Developmental TCDD exposure can permanently alter T lymphopoiesis in autoimmune-prone SNF1 mice. The alteration profile is beyond the classic immune suppression response, to also include exacerbation and induction of a lupuslike autoimmune disease. FAU - Mustafa, Amjad AU - Mustafa A AD - Center for Molecular Medicine and Infectious Diseases, Department of Biomedical Sciences and Pathobiology, Virginia-Maryland Regional College of Veterinary Medicine, Virginia Polytechnic Institute and State University Blacksburg, Virginia, USA. FAU - Holladay, Steven D AU - Holladay SD FAU - Goff, Matthew AU - Goff M FAU - Witonsky, Sharon AU - Witonsky S FAU - Kerr, Richard AU - Kerr R FAU - Weinstein, Danielle A AU - Weinstein DA FAU - Karpuzoglu-Belgin, Ebru AU - Karpuzoglu-Belgin E FAU - Gogal, Robert M Jr AU - Gogal RM Jr LA - eng GR - R21 ES013811-03/ES/NIEHS NIH HHS/United States GR - R21-PAR-03-121/PHS HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PL - United States TA - Birth Defects Res A Clin Mol Teratol JT - Birth defects research. Part A, Clinical and molecular teratology JID - 101155107 RN - 0 (Cytokines) RN - 0 (Polychlorinated Dibenzodioxins) SB - IM MH - Animals MH - Autoimmune Diseases/immunology/*physiopathology MH - Body Weight/drug effects MH - Cell Differentiation/drug effects MH - Cytokines/metabolism MH - Enzyme-Linked Immunosorbent Assay MH - Female MH - Flow Cytometry MH - Immunohistochemistry MH - Lupus Nephritis/immunology/*physiopathology MH - Male MH - Mice MH - Organ Size/drug effects MH - Polychlorinated Dibenzodioxins/*toxicity MH - Pregnancy MH - T-Lymphocytes/cytology/*drug effects/immunology PMC - PMC2760641 MID - NIHMS138024 EDAT- 2009/07/03 09:00 MHDA- 2009/12/16 06:00 PMCR- 2010/10/01 CRDT- 2009/07/03 09:00 PHST- 2009/07/03 09:00 [entrez] PHST- 2009/07/03 09:00 [pubmed] PHST- 2009/12/16 06:00 [medline] PHST- 2010/10/01 00:00 [pmc-release] AID - 10.1002/bdra.20603 [doi] PST - ppublish SO - Birth Defects Res A Clin Mol Teratol. 2009 Oct;85(10):828-36. doi: 10.1002/bdra.20603.